These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 11186505

  • 1. Proton pump inhibitors: cost-effective agents for management of reflux-induced esophagitis.
    Gregor JC.
    Am J Manag Care; 2000 Aug; 6(8):934-5. PubMed ID: 11186505
    [No Abstract] [Full Text] [Related]

  • 2. Cost effectiveness of rabeprazole versus generic ranitidine for symptom resolution in patients with erosive esophagitis.
    Ofman JJ, Yamashita BD, Siddique RM, Larson LR, Willian MK.
    Am J Manag Care; 2000 Aug; 6(8):905-16. PubMed ID: 11186502
    [Abstract] [Full Text] [Related]

  • 3. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA, Kuppermann M, Richter JE.
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [Abstract] [Full Text] [Related]

  • 4. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
    Bardou M.
    Rev Prat; 2001 Apr 15; 51(7):789-95. PubMed ID: 11387678
    [No Abstract] [Full Text] [Related]

  • 5. [Cost-effectiveness of the treatment of reflux esophagitis: proton pump inhibitor versus histamine-2-receptor antagonist].
    Habu Y, Oyasu K, Wakamatsu T, Sumitomo Y, Kiyota K, Inokuchi H, Kawai K.
    Nihon Rinsho; 2000 Sep 15; 58(9):1881-5. PubMed ID: 11004820
    [Abstract] [Full Text] [Related]

  • 6. [Continuation of acid suppression therapy after H. pylori eradication].
    Takahashi M, Kuwayama H.
    Nihon Rinsho; 2002 Feb 15; 60 Suppl 2():531-5. PubMed ID: 11979841
    [No Abstract] [Full Text] [Related]

  • 7. [Evaluation of the efficacy and the cost-effectiveness of maintenance treatment of gastroesophageal reflux disease: proton pump inhibitor versus histamine-2-receptor antagonist].
    Habu Y, Yoshino T, Shio S, Hayakumo T, Kawai K.
    Nihon Rinsho; 2004 Aug 15; 62(8):1504-9. PubMed ID: 15344541
    [Abstract] [Full Text] [Related]

  • 8. Antisecretory drugs, Helicobacter pylori infection and symptom relief in GORD: still an unexplored triangle.
    Scarpignato C.
    Dig Liver Dis; 2005 Jul 15; 37(7):468-74. PubMed ID: 15893968
    [No Abstract] [Full Text] [Related]

  • 9. Proton pump inhibitors.
    Grover JK, Vats V.
    Trop Gastroenterol; 1999 Jul 15; 20(1):16-28. PubMed ID: 10464444
    [No Abstract] [Full Text] [Related]

  • 10. Utility of proton pump inhibitors in the treatment of gastrointestinal hemorrhage.
    Martin RA.
    Conn Med; 2004 Aug 15; 68(7):435-8. PubMed ID: 15384242
    [Abstract] [Full Text] [Related]

  • 11. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ, Hunt RH.
    Yale J Biol Med; 1999 Aug 15; 72(2-3):181-94. PubMed ID: 10780580
    [Abstract] [Full Text] [Related]

  • 12. [Graded therapy in reflux disease. "In severe cases 40 mg., in milder 20 mg."].
    Gillessen A.
    MMW Fortschr Med; 2004 Mar 11; 146(11):54. PubMed ID: 15152771
    [No Abstract] [Full Text] [Related]

  • 13. Effectiveness of proton pump inhibitors: beyond cost.
    Katz PO.
    Rev Gastroenterol Disord; 2004 Mar 11; 4 Suppl 4():S8-S15. PubMed ID: 15580146
    [Abstract] [Full Text] [Related]

  • 14. [When sour does not make merry at all . Fast relief for patients with reflux].
    MMW Fortschr Med; 2003 Apr 10; 145(15):64. PubMed ID: 15104274
    [No Abstract] [Full Text] [Related]

  • 15. Long-term management of gastroesophageal reflux disease and its complications.
    Richter JE.
    Am J Gastroenterol; 1997 Apr 10; 92(4 Suppl):30S-34S; discussion 34S-35S. PubMed ID: 9127624
    [Abstract] [Full Text] [Related]

  • 16. PPIs vs H2RAs for erosive reflux esophagitis.
    King VJ.
    J Fam Pract; 1998 Mar 10; 46(3):199-200. PubMed ID: 9519012
    [No Abstract] [Full Text] [Related]

  • 17. Proton pump inhibitors: an update.
    Vanderhoff BT, Tahboub RM.
    Am Fam Physician; 2002 Jul 15; 66(2):273-80. PubMed ID: 12152963
    [Abstract] [Full Text] [Related]

  • 18. [Comparative clinical and economic efficiency of new generation proton pump inhibitors in the treatment of gastroesophageal reflux].
    Starostin BD, Starostina GA.
    Eksp Klin Gastroenterol; 2003 Jul 15; (5):35-9. PubMed ID: 14621608
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of gastroesophageal reflux disease: to step or not to step.
    McGuigan JE.
    Am J Gastroenterol; 2001 Jun 15; 96(6):1679-81. PubMed ID: 11419813
    [No Abstract] [Full Text] [Related]

  • 20. Impact of proton pump inhibitor utilization patterns on gastroesophageal reflux disease-related costs.
    Hall J, Dodd S, Durkin M, Sloan S.
    Manag Care; 2002 Jul 15; 11(7 Suppl):14-8. PubMed ID: 12181872
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.